by Joris Van Arensbergen | May 12, 2025 | News, SURE Technology
Amsterdam, The Netherlands – May 12, 2025 Orchard Therapeutics, a Kyowa Kirin company focused on innovative gene therapies, and Annogen B.V., experts in bespoke promoter design and gene expression engineering, today announced the successful identification of...
by Joris Van Arensbergen | May 7, 2025 | News, SURE Technology
Amsterdam, The Netherlands – May 7, 2025 Ascend Advanced Therapies and Annogen will combine their expertise in AAV biology, vector manufacturing and genetic engineering to improve the quality of recombinant AAV particles used in gene therapy applications. While AAV...
by admin | Mar 10, 2025 | FACE technology, News
New collaboration in crop engineering Collaborating on functional annotation to accelerate crop improvement Corteva Agriscience™ and Annogen B.V. are working together to functionally annotate thousands of expression elements in maize. Leveraging Annogen’s...
by admin | Jan 23, 2025 | FACE technology, News
We’re thrilled to share that our Founder & CEO, Joris van Arensbergen, has been invited to speak at the prestigious Crop Innovation and Business (CIB) Conference in Cologne, taking place from 30 March – 1 April 2025. Joris will be delivering a talk on Large-scale...
by admin | Dec 12, 2024 | News, SURE Technology
UCSF, Annogen Announce Collaboration to Identify Superior Treg-Specific Promoters Annogen, a leader in gene expression engineering, and the prestigious labs of Qizhi Tang and Brian Shy at University of California, San Francisco (UCSF) today announced a collaboration...
by admin | Dec 9, 2024 | FACE technology, News, Uncategorized
Einbeck, Germany; Amsterdam, The Netherlands December 5, 2024 KWS SAAT SE & Co. KGaA and Annogen B.V. today announced a partnership in which Annogen will use its FACE™ platform to functionally annotate non-coding variants that are of interest to KWS. FACE™ is an...
